# A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants

> **NCT07118878** · PHASE1 · COMPLETED · sponsor: **Agomab Spain S.L.U.** · enrollment: 30 (actual)

## Conditions studied

- Fibrostenotic Crohn's Disease

## Interventions

- **DRUG:** AGMB-129
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07118878
- **Lead sponsor:** Agomab Spain S.L.U.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-06
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-09-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07118878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07118878, "A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07118878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*